Protocol For Collecting Data On Patients With Childhood Cancer
ConditionChildhood Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSt. Jude Children's Research Hospital
About this trial
Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All St Jude patients actively being followed or treated for childhood cancer
Disqualifiers
St. Jude consult only patients
St. Jude patients permanently discharged from care and follow-up Permanently discharged patients include patients who have electively transferred their oncologic care to another institution, those who are noncompliant with recommended follow-up or those leaving the institution against medical advice.
Patients referred to St. Jude for limited care on phase 1 protocol.
Trial population
All patients actively being treated and previously treated at St. Jude Children's Research Hospital for childhood cancer.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Data Collection
Other interventionContinuing review of outcomes and late toxicities
Treatment groups
30,000 Participants
are divided into 1 treatment groupGroup A: Observational Group1 intervention
Trial outcomes
Primary outcomes
1
To provide continuing review of outcome and late toxicity for all patients actively being followed or treated for childhood cancer at St. Jude Children's Research Hospital, all St Jude Alumni and all St. Life participants.
Time frame
25 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov